Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-22 Purchase |
2023-09-22 7:34 pm |
Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO and COO |
5,000 | $1.739 | $8,695 | 792,106 (Direct) |
View |
| 2023-09-14 Sale |
2023-09-18 7:03 pm |
Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO |
8,641 | $2.1017 | $18,161 | 2,403,882 (Direct) |
View |
| 2023-09-11 Sale |
2023-09-13 8:16 pm |
Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO |
27,917 | $2.2675 | $63,301 | 2,412,523 (Direct) |
View |
| 2023-03-17 Purchase(A) |
2023-03-23 4:14 pm |
Pyxis Oncology Inc. | PYXS | PFIZER INC Pfizer Ventures (US) LLC 10% Owner |
1,811,594 | $2.76 | $4,999,999 | 5,952,263 (Direct) |
View |
| 2023-03-17 Purchase |
2023-03-21 6:07 pm |
Pyxis Oncology Inc. | PYXS | PFIZER INC Pfizer Ventures (US) LLC 10% Owner |
1,811,594 | $2.76 | $4,999,999 | 7,032,770 (Indirect Direct) |
View |
| 2022-04-21 Sale |
2022-04-25 12:12 pm |
Pyxis Oncology Inc. | PYXS | Chin Mark Former Director Director |
1,745,761 | $3.05 | $5,324,571 | 0 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-09-13 Tax Withholding |
2023-09-13 8:16 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO |
184,742 | $2.13 | 2,412,523 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 5:02 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Connealy Pamela Ann CFO and COO |
187,793 | $0 | 782,106 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 5:01 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Wadhane Jitendra Chief Accounting Officer |
93,896 | $0 | 211,937 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-08 5:00 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO |
469,483 | $0 | 2,625,182 (Direct) |
View |
| 2023-08-23 Option Award |
2023-08-25 5:30 pm |
N/A 2030-09-01 |
Pyxis Oncology Inc. | PYXS | Dupont Jakob Director |
26,663 | $0 | 26,663 (Direct) |
View |
| 2023-03-24 Option Award |
2023-03-28 4:48 pm |
N/A 2031-03-30 |
Pyxis Oncology Inc. | PYXS | Sullivan Lara President and CEO |
1,755,665 | $0 | 3,207,985 (Direct) |
View |
| 2023-03-24 Option Award |
2023-03-28 4:47 pm |
N/A 2031-07-30 |
Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela CFO and COO |
542,372 | $0 | 926,882 (Direct) |
View |
| 2023-03-24 Option Award |
2023-03-28 4:45 pm |
N/A 2031-09-12 |
Pyxis Oncology Inc. | PYXS | Feingold Jay Chief Medical Officer |
384,577 | $0 | 905,119 (Direct) |
View |
| 2023-03-24 Option Award |
2023-03-28 4:45 pm |
N/A 2031-07-30 |
Pyxis Oncology Inc. | PYXS | Wadhane Jitendra Chief Accounting Officer |
231,650 | $0 | 245,905 (Direct) |
View |
| 2023-03-24 Option Award |
2023-03-28 4:44 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Lewis-Hall Freda C Director |
139,355 | $0 | 206,186 (Direct) |
View |
| 2023-03-24 Option Award |
2023-03-28 4:43 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director |
58,064 | $0 | 58,064 (Direct) |
View |
| 2023-03-24 Option Award |
2023-03-28 4:43 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | FLAVIN JOHN L Director |
139,355 | $0 | 377,796 (Direct) |
View |
| 2023-03-24 Option Award |
2023-03-28 4:41 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Cline Darren S Director |
139,355 | $0 | 216,186 (Direct) |
View |
| 2023-03-24 Option Award |
2023-03-28 4:41 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Civik Thomas Director |
139,355 | $0 | 221,886 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-03 7:39 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer |
95,684 | $0 | 1,452,320 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-03 7:38 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Feingold Jay Chief Medical Officer |
53,931 | $0 | 520,542 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-03 7:37 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela Chief Financial Officer |
43,493 | $0 | 384,510 (Direct) |
View |
Ownership |
2022-10-13 08:34 am |
N/A N/A |
Pyxis Oncology Inc. | PYXS | PFIZER INC Pfizer Ventures (US) LLC 10% Owner |
0 | $0 | 5,221,176 (Direct) |
View |
| 2022-08-11 Option Award |
2022-08-15 5:44 pm |
N/A 2032-08-11 |
Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director |
236,220 | $0 | 236,220 (Direct) |
View |
Ownership |
2022-08-09 4:34 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Wadhane Jitendra SVP, Chief Accounting Officer |
0 | $0 | 200,905 (Direct) |
View |
Ownership |
2022-04-26 1:40 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | BARCLAYS PLC 10% Owner |
0 | $0 | 3,477,975 (Indirect) |
View |
| 2022-04-14 Option Award |
2022-04-15 8:00 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela Chief Financial Officer |
93,493 | $0 | 341,017 (Direct) |
View |
| 2022-04-14 Option Award |
2022-04-15 7:58 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Feingold Jay Chief Medical Officer |
115,931 | $0 | 466,611 (Direct) |
View |
| 2022-04-14 Option Award |
2022-04-15 7:56 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer |
315,273 | $0 | 1,356,636 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 4:16 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | FLAVIN JOHN L Director |
66,831 | $0 | 238,441 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 4:16 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Feingold Jay Chief Medical Officer |
306,930 | $0 | 350,680 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 4:15 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Sullivan Lara Chief Executive Officer |
742,574 | $0 | 1,041,363 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 4:15 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Civik Thomas Director |
66,831 | $0 | 82,531 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 4:15 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Chin Mark Director |
66,831 | $0 | 1,812,592 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 4:15 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Cline Darren S Director |
66,831 | $0 | 76,831 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 4:15 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela Chief Financial Officer |
247,524 | $0 | 247,524 (Direct) |
View |
| 2022-03-31 Option Award |
2022-04-04 4:15 pm |
N/A N/A |
Pyxis Oncology Inc. | PYXS | Lewis-Hall Freda C Director |
66,831 | $0 | 66,831 (Direct) |
View |